NYSE:ELV
NYSE:ELVHealthcare

Is It Time To Revisit Elevance Health (ELV) After Recent Share Price Weakness

If you are wondering whether Elevance Health's current share price offers good value or not, it helps to look past the headlines and focus on what the numbers are saying. The stock last closed at US$345.74, with returns of a 6.8% decline over 7 days, a 2.4% decline over 30 days, a 2.4% decline year to date, and a 10.9% decline over 1 year, while the 5 year return sits at 27.2%. Recent news around Elevance Health has centered on broader healthcare policy discussions and insurer sentiment,...
NYSE:PFE
NYSE:PFEPharmaceuticals

Pfizer Reshapes Portfolio With Metsera Deal And Obesity Oncology Pivot

Pfizer agreed to acquire Metsera for $10 billion, aiming to expand into obesity and weight loss drugs. The company is reshaping its R&D focus toward metabolic disease, oncology and immunology. Pfizer signed a licensing deal with Novavax for Matrix M adjuvant technology to support vaccine development. Pfizer (NYSE:PFE), trading around $26.44, is trying to reposition itself after a difficult multi year share price period, with a reported 28.1% decline over 3 years and 2.8% decline over 5...
NYSE:PLNT
NYSE:PLNTHospitality

Is Planet Fitness (PLNT) Fairly Priced After Recent Share Price Weakness And Fitness Stock Debate

If you are wondering whether Planet Fitness shares offer good value at current levels, this article walks through what the numbers actually say about the stock. The share price closed at US$91.04, with returns of a 3.6% decline over the last 7 days, 17.0% decline over 30 days, 17.0% decline year to date, 15.8% decline over 1 year, 11.1% gain over 3 years and 17.0% gain over 5 years, which gives a mixed picture for anyone thinking about long term performance. Recent news flow around Planet...
NasdaqGS:MDLZ
NasdaqGS:MDLZFood

A Look At Mondelez International (MDLZ) Valuation As CFO Luca Zaramella Takes On COO Role

Mondelez International (MDLZ) has put leadership in sharper focus, asking long-time Chief Financial Officer Luca Zaramella to also serve as Chief Operating Officer, centralizing financial and commercial decision making under one experienced executive. See our latest analysis for Mondelez International. The leadership reshuffle comes as the share price trades at US$58.47, with a 1 month share price return of 8.98% and a 1 year total shareholder return of 4.01%, while the 3 year total...
NYSE:KEYS
NYSE:KEYSElectronic

Does Keysight’s (KEYS) AI Interconnect Testing Push Reveal a Deeper Competitive Shift in Datacenters?

On January 29, 2026, Keysight Technologies and Point2 Technology announced a collaboration to validate Point2’s e-Tube interconnects aimed at easing AI and machine learning data center bottlenecks using Keysight’s high-speed digital test platforms. The partnership highlights how test and measurement expertise can become a critical enabler for hyperscalers seeking lower-power, longer-reach alternatives to traditional copper and optics in xPU clusters. With this AI-focused collaboration in...
NasdaqGS:PWP
NasdaqGS:PWPCapital Markets

A Look At Perella Weinberg Partners (PWP) Valuation After Recent Share Price Momentum

Why Perella Weinberg Partners (PWP) is on investors’ radar Perella Weinberg Partners (PWP) has drawn attention after a month return of about 27% and a past 3 months gain of roughly 21%, prompting investors to reassess its advisory driven business and recent financial metrics. See our latest analysis for Perella Weinberg Partners. The recent 30 day share price return of 27.1% and 90 day gain of 20.6% at a latest share price of $22.31 suggest building momentum. This comes alongside a mixed...
NasdaqGS:VNOM
NasdaqGS:VNOMOil and Gas

Is Viper Energy (VNOM) Still Attractive After Recent Permian Royalty Headlines And Price Rebound

If you are wondering whether Viper Energy at around US$42.34 still offers value, you are not alone, especially with energy stocks often moving in sharp cycles. Over the last week the share price return was 6.8%, with a 9.2% return over the past month, although the return over the last year was a 4.3% decline. Recent news flow around Viper Energy has focused on its role as a mineral and royalty interest owner in the Permian Basin and how its asset base ties into broader US oil and gas...
NasdaqGS:META
NasdaqGS:METAInteractive Media and Services

Meta Patent Dispute Puts Smart Glasses And AR Ambitions Under Scrutiny

Solos Technology has filed a patent infringement lawsuit against Meta Platforms (NasdaqGS:META) over smart glasses technology. The complaint targets Meta's Ray-Ban smart glasses and claims infringement of multiple Solos patents tied to audio, sensing, and real-time user interaction. Solos is seeking significant damages and an injunction that could affect Meta's wearables business and broader platform plans. The lawsuit also cites alleged internal awareness at Meta of Solos' patents before...
NYSE:OHI
NYSE:OHIHealth Care REITs

Assessing Omega Healthcare Investors (OHI) Valuation After Wells Fargo Downgrade And Target Cut

Omega Healthcare Investors (OHI) is back in focus after Wells Fargo cut its rating to Equal Weight and trimmed its target, arguing the REIT’s valuation looks full at current prices for now. See our latest analysis for Omega Healthcare Investors. At a share price of $43.88, Omega Healthcare Investors has seen modest recent moves, with a 4.5% 90 day share price return and a 26.9% 1 year total shareholder return. This indicates that momentum has been building over the longer term despite shorter...
NasdaqGS:KLAC
NasdaqGS:KLACSemiconductor

Is It Too Late To Consider KLA (KLAC) After A 95% One Year Surge?

If you are wondering whether KLA's current share price still offers value after a strong run, this article will walk through what the numbers actually say about the stock. Over the last year, KLA returned 95.1%, with a 12.0% gain over the past month but a 5.6% decline in the last week, which may have shifted how investors think about both its upside and risk. Recently, KLA has been in focus as part of broader interest in semiconductor and chip equipment companies, with headlines frequently...
NYSE:GRC
NYSE:GRCMachinery

Dividend Hike and Backlog Strength Could Be A Game Changer For Gorman-Rupp (GRC)

The Board of Directors of The Gorman-Rupp Company recently declared a quarterly cash dividend of US$0.19 per share, payable on March 10, 2026, to shareholders of record as of February 13, 2026. This dividend decision comes alongside evidence of strong multi-year revenue, backlog, and earnings expansion, suggesting the payout is being supported by solid underlying business momentum. Next, we will consider how this combination of a US$0.19 quarterly dividend and robust backlog growth shapes...